irinotecan has been researched along with silicon in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, DR; Huh, E; Jang, JE; Kang, JS; Kang, RH; Kang, SJ; Kim, D; Kim, HY; Oh, MS; Sailor, MJ; Yeo, SG | 1 |
| Jang, HJ; Kang, RH; Kim, D; Kim, JH; Kim, JS; Kim, NH; Kim, Y; Ko, HM; Lee, SH; Shim, I | 1 |
2 other study(ies) available for irinotecan and silicon
| Article | Year |
|---|---|
A brain tumor-homing tetra-peptide delivers a nano-therapeutic for more effective treatment of a mouse model of glioblastoma.
Topics: Animals; Annexin A3; Antineoplastic Agents; Cell Line, Tumor; Cell-Penetrating Peptides; Drug Carriers; Female; Glioblastoma; Humans; Irinotecan; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Oligopeptides; Peptide Fragments; Polyethylene Glycols; Silicon; Xenograft Model Antitumor Assays | 2020 |
Self-Activating Therapeutic Nanoparticle: A Targeted Tumor Therapy Using Reactive Oxygen Species Self-Generation and Switch-on Drug Release.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Liberation; Female; Humans; Irinotecan; Isothiocyanates; Male; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasms; Oligopeptides; Photosensitizing Agents; Precision Medicine; Prodrugs; Reactive Oxygen Species; Silanes; Silicon; Xenograft Model Antitumor Assays | 2021 |